Neurochemical studies with the novel anticonvulsant levetiracetam in mouse brain

European Journal of Pharmacology

Volumn 325, Issue 1, 1997, Pages 35-40

  Sills, Graeme J ^a   Leach, John Paul ^a   Fraser, Caroline M ^a   Forrest, Gerard ^a   Patsalos, Philip N ^b   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti epileptic drug; Epilepsy; GABA ( aminobutyric acid); Levetiracetam

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ETIRACETAM; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GLUTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; GABAERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

4-AMINOBUTYRATE TRANSAMINASE; ANIMALS; ANTICONVULSANTS; BRAIN; DRUG ADMINISTRATION SCHEDULE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; GLUTAMINE; MALE; MICE; MICE, INBRED ICR; PIRACETAM;

EID: 0030929702     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00105-2     Document Type: Article

References (22)

1. Coulter, D.A., Sombati, S., DeLorenzo, R.J., 1995. Topiramate effects on excitatory amino acid-mediated responses in cultured hippocampal neurons: selective blockade of kainate currents. Epilepsia 36, S40.
2. Davies, J.A., 1995. Mechanisms of action of antiepileptic drugs. Seizure 4, 267-272.
3. Durkin, T.A., Anderson, G.M., Cohen, D.J., 1988. High-performance liquid chromatographic analysis of neurotransmitter amino acids in brain. J. Chromatogr. 428, 9-15.
4. Gower, A.J., Noyer, M., Verloes, R., Gobert, J., Wülfert, E., 1992. ucb LO59, a novel anti-convulsant drug: pharmacological profile in animals. Eur. J. Pharmacol. 222, 193-203.
5. Gower, A.J., Hirsch, E., Boehrer, A., Noyer, M., Marescaux, C., 1995. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res. 22, 207-213.
6. Kochhar, S., Mehta, P.K., Christen, P., 1989. Assay for aliphatic amino acid decarboxylases by high-performance liquid chromatography. Anal. Biochem. 179, 182-185.
7. Larsson, O.M., Gram, L., Schousboe, I., Schousboe, A., 1986. Differential effect of gamma-vinyl GABA and valproate on GABA-transaminase from cultured neurones and astrocytes. Neuropharmacology 25, 617-625.
8. Leach, J.P., Sills, G.J., Butler, E., Forrest, G., Thompson, G.G., Brodie, M.J., 1997. Neurochemical actions of gabapentin in mouse brain. Epilepsy Res. (in press).
9. Löscher, W., Hönack, D., 1993. Profile of ucb LO59, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur. J. Pharmacol. 232, 147-158.
10. Löscher, W., Schmidt, D., 1988. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2, 145-181.
11. Löscher, W., Schmidt, D., 1993. New drugs for the treatment of epilepsy. Curr. Opin. Invest. Drugs 2, 1067-1095.
12. Margineanu, D.G., Wülfert, E., 1995. ucb LO59, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Eur. J. Pharmacol. 286, 321-325.
13. Noyer, M., Gillard, M., Matagne, A., Hénichart, J.-P., Wülfert, E., 1995. The novel antiepileptic drug levetiracetam (ucb LO59) appears to act via a specific binding site in CNS membranes. Eur. J. Pharmacol. 286, 137-146.
14. Rogawski, M.A., Porter, R.J., 1990. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42, 223-286.
15. Saccan, A.I., Lloyd, G.K., 1994. The binding of the anticonvulsant levetiracetam to rat brain membranes distinguishes a novel site relevant to antiepileptic drug activity. Neuropsychopharmacology 10, 133S.
16. Schmidt, J., 1990. Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats. Biochim. Biophys. Acta 1049, 413-419.
17. Sharief, M.K., Singh, P., Sander, J.W.A.S., Patsalos, P.N., Shorvon, S.D., 1996. Efficacy and tolerability study of ucb LO59 in patients with refractory epilepsy. J. Epilepsy 9, 106-112.
18. Stables, J.P., Bialer, M., Johannessen, S.I., Kupferberg, H.J., Levy, R.H., Loiseau, P., Perucca, E., 1995. Progress report on new antiepileptic drugs. A summary of the second Eilat conference. Epilepsy Res. 22, 235-246.
19. Vergnes, M., Marescaux, C., Micheletti, G., Depaulis, A., Rumbach, L., Warter, J.M., 1984. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit mal-like epilepsy. Neurosci. Lett. 44, 91-94.
20. White, H.L., Sato, T.L., 1978. GABA-transaminases of human brain and peripheral tissues-kinetic and molecular properties. J. Neurochem. 31, 41-47.
21. White, H.S., Brown, D., Skeen, G.A., Wolf, H.H., Twyman, R.E., 1995. The anticonvulsant topiramate displays a unique ability to potentiate GABA-evoked chloride currents. Epilepsia 36, S39.
22. Wolf, R., Klemisch, H., 1991. Adaptation of an enzymatic fluorescence assay for L-glutamic acid decarboxylase. Anal. Biochem. 192, 78-81.